The Authorized Generic Strategy
A common market dynamic in 2026 is the use of Authorized Generics. These are the exact same drug products as the brand-name version, but sold without the brand label, often by the original patent holder or a licensed partner.
Competitive Maneuver: Brand-name companies launch authorized generics to capture the lower-cost market segment before "pure" generic competitors can enter.
Patient Benefit: For the consumer, an authorized generic provides the "peace of mind" of the original manufacturer’s formulation at a significantly lower price point, often serving as the first wave of competition during the initial 180-day exclusivity period.
1 View